Sealonix
Bedford
About Sealonix
Sealonix focuses on the development and commercialization of hemostatic sealants using its proprietary biomaterials. Sealonix is working on a sealant patch that will provide quick hemostasis for abdominopelvic and orthopedic operations. The PramStat patch is intended to bioabsorb within one week of implantation.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $20.0M
- Funding stage: Early Stage Venture
- Last round: Series A (May 2023)
- Website: sealonix.com
- Phone: 781-222-0081
Industries & Categories
Advanced Materials, Biotechnology, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/sealonix-40699 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.